OEL buys 51% stake in Shanghai Longjian Hospital Management

Its doctors are using a hydrogen generator for treating COVID-19 in China.

Catalist-listed OEL (Holdings) has completed the acquisition of 51% share in Shanghai Longjian Hospital Management through the company’s wholly owned subsidiary AJJ Health Care Management, for an undisclosed amount, according to a press release.

With this, Shanghai Longjian becomes an indirect subsidiary of the company, held through AJJ.

As was announced on 12 March, the doctors of Shanghai Longjian are providing medical treatment guidance and services on the usage of the hydrogen generator for the treatment of COVID-19 in China.

Ye Wenzheng is the founder and legal representative of Shanghai Longjian. In addition, Shanghai Longjian has also gathered medical, pharmaceutical and hospital management experts to form its medical team.